Skip Navigation
Skip to contents

Cancer Res Treat : Cancer Research and Treatment

OPEN ACCESS

Previous issues

Page Path
HOME > Browse articles > Previous issues
10 Previous issues
Filter
Filter
Article category
Keywords
Authors
Volume 41(4); December 2009
Prev issue Next issue
Review Article
Significance of Cellular Senescence in Aging and Cancer
Angela Grimes, Sathees B.C. Chandra
Cancer Res Treat. 2009;41(4):187-195.   Published online December 31, 2009
DOI: https://doi.org/10.4143/crt.2009.41.4.187
AbstractAbstract PDFPubReaderePub

Cellular senescence is a mechanism that induces an irreversible growth arrest in all somatic cells. Senescent cells are metabolically active but lack the capacity to replicate. Evolutionary theories suggest that cellular senescence is related to the organismal decline occurring in aging organisms. Also, such theories describe senescence as an antagonistically pleiotropic process that can have beneficial or detrimental effect on the organism. Cellular senescence is believed to be involved in the cellular changes observed as aging progresses. Accumulation of senescent cells appears to occur widely as the organism ages. Furthermore, senescence is a key element of the tumor suppressor pathways. Therefore, it is part of the natural barrier against the uncontrolled proliferation observed in cellular development of malignancies in multicellular organisms. Activation of the senescence process guarantees a limited number of cellular replications. The genetic network led by p53 is responsible for activation of senescence in response to DNA damage and genomic instability that could lead to cancer. A better comprehension of the genetic networks that control the cell cycle and induce senescence is important to analyze the association of senescence to longevity and diseases related to aging. For these reasons, experimental research both in vitro and in vivo aims to develop anticancer therapies based on senescence activation. The last decade of research on role and function of senescence in aging and cancer are discussed in this paper.

Citations

Citations to this article as recorded by  
  • RNA binding proteins (RBPs) on genetic stability and diseases
    Abdullahi Tunde Aborode, Ohilebo Abdulateef Abass, Shaibu Nasiru, Mary Ugunnushe Eigbobo, Sumana Nefishatu, Abdullahi Idowu, Zainab Tiamiyu, Aeshah A. Awaji, Nike Idowu, Babawale Roqeeb Busayo, Qasim Mehmood, Isreal Ayobami Onifade, Sodiq Fakorede, Ashraf
    Global Medical Genetics.2025; 12(1): 100032.     CrossRef
  • Development of long-term primary cell culture of Macrobrachium rosenbergii: morphology, metabolic activity, and cell-cycle analysis
    Gurucharan Sudarshan, Simy Weil, Rivka Manor, Oron Goldstein, Eliya Sultan, Eliahu D. Aflalo, Rivka Ofir, Sean V. Zimin, Benyamin Rosental, Amir Sagi
    Frontiers in Marine Science.2024;[Epub]     CrossRef
  • Immunotherapy: should we worry about immunosenescence?
    Asli Özkan, Nienke A. de Glas, Johanneke E. A. Portielje
    Ageing and Cancer Research & Treatment.2024;[Epub]     CrossRef
  • DLL3 Is a Prognostic and Potentially Predictive Biomarker for Immunotherapy Linked to PD/PD-L Axis and NOTCH1 in Pancreatic Cancer
    Carlos Lacalle-Gonzalez, Maria Florez-Cespedes, Lara Sanz-Criado, Michael Ochieng’ Otieno, Edurne Ramos-Muñoz, Maria Jesus Fernandez-Aceñero, Luis Ortega-Medina, Jesus Garcia-Foncillas, Javier Martinez-Useros
    Biomedicines.2023; 11(10): 2812.     CrossRef
  • Clinical features and prognostic factors of elderly patients with metastatic pancreatic cancer: a population-based study
    Tao Lianyuan, Li Deyu, Yu Haibo, Dong Yadong, Tian Guanjing
    Aging.2021; 13(5): 7133.     CrossRef
  • Cancer in old population: We need more practice
    Siyi Zou, Baiyong Shen
    Aging and Cancer.2021; 2(1-2): 4.     CrossRef
  • Acetyl‐11‐keto‐β‐boswellic acid triggers premature senescence via induction of DNA damage accompanied by impairment of DNA repair genes in hepatocellular carcinoma cells in vitro and in vivo
    Shikang Wang, Huijun Wang, Baoyou Sun, Duanfeng Li, Jing Wu, Juan Li, Xiaona Tian, Chengkun Qin, Hong Chang, Yongqing Liu
    Fundamental & Clinical Pharmacology.2020; 34(1): 65.     CrossRef
  • The self-organization model reveals systematic characteristics of aging
    Yin Wang, Tao Huang, Yixue Li, Xianzheng Sha
    Theoretical Biology and Medical Modelling.2020;[Epub]     CrossRef
  • Atorvastatin-induced senescence of hepatocellular carcinoma is mediated by downregulation of hTERT through the suppression of the IL-6/STAT3 pathway
    Sin-Ting Wang, Shi-Wei Huang, Kuang-Ting Liu, Teng-Yu Lee, Jeng-Jer Shieh, Chun-Ying Wu
    Cell Death Discovery.2020;[Epub]     CrossRef
  • ATM Protein Kinase: Old and New Implications in Neuronal Pathways and Brain Circuitry
    Lara Pizzamiglio, Elisa Focchi, Flavia Antonucci
    Cells.2020; 9(9): 1969.     CrossRef
  • The Regulatory Properties of the Ccr4–Not Complex
    Nafiseh Chalabi Hagkarim, Roger J. Grand
    Cells.2020; 9(11): 2379.     CrossRef
  • Immunosenescence - the sunset over the immune system
    Zita Chovancová
    Vnitřní lékařství.2020; 66(6): 353.     CrossRef
  • The OncoAge Consortium: Linking Aging and Oncology from Bench to Bedside and Back Again
    Paul Hofman, Nicholas Ayache, Pascal Barbry, Michel Barlaud, Audrey Bel, Philippe Blancou, Frédéric Checler, Sylvie Chevillard, Gael Cristofari, Mathilde Demory, Vincent Esnault, Claire Falandry, Eric Gilson, Olivier Guérin, Nicolas Glaichenhaus, Joel Gui
    Cancers.2019; 11(2): 250.     CrossRef
  • Induction of ROS and DNA damage-dependent senescence by icaritin contributes to its antitumor activity in hepatocellular carcinoma cells
    Shikang Wang, Qian Wang, Huijun Wang, Chengkun Qin, Xianping Cui, Lei Li, Yongqing Liu, Hong Chang
    Pharmaceutical Biology.2019; 57(1): 424.     CrossRef
  • Artemether Attenuates the Progression of Non-small Cell Lung Cancer by Inducing Apoptosis, Cell Cycle Arrest and Promoting Cellular Senescence
    Jian Chen, Xiaofei Huang, Cheng Tao, Ting Xiao, Xinping Li, Qiang Zeng, Min Ma, Zhengzhi Wu
    Biological and Pharmaceutical Bulletin.2019; 42(10): 1720.     CrossRef
  • V79 Fibroblasts Are Protected Against Reactive Oxygen Species by Flax Fabric
    Katarzyna Skórkowska-Telichowska, Anna Kulma, Tomasz Gębarowski, Wioleta Wojtasik, Kamil Kostyn, Helena Moreira, Anna Szyjka, Aleksandra Boba, Marta Preisner, Justyna Mierziak, Malgorzata Arendt, Anna Kostyn, Michał Szatkowski, Jan Szopa, Kazimierz Gąsior
    Applied Biochemistry and Biotechnology.2018; 184(1): 366.     CrossRef
  • A framework for how environment contributes to cancer risk
    Michael E. Hochberg, Robert J. Noble, Kevin Lafferty
    Ecology Letters.2017; 20(2): 117.     CrossRef
  • New Progress in Ginseng Anti-Aging Effects on Blood and Cardiovascular System
    慧娟 张
    Pharmacy Information.2017; 06(05): 95.     CrossRef
  • Protein carbamylation is a hallmark of aging
    Laëtitia Gorisse, Christine Pietrement, Vincent Vuiblet, Christian E. H. Schmelzer, Martin Köhler, Laurent Duca, Laurent Debelle, Paul Fornès, Stéphane Jaisson, Philippe Gillery
    Proceedings of the National Academy of Sciences.2016; 113(5): 1191.     CrossRef
  • Cristacarpin promotes ER stress-mediated ROS generation leading to premature senescence by activation of p21waf-1
    Souneek Chakraborty, Reyaz ur Rasool, Sunil Kumar, Debasis Nayak, Bilal Rah, Archana Katoch, Hina Amin, Asif Ali, Anindya Goswami
    AGE.2016;[Epub]     CrossRef
  • Integrative analysis of methylation and transcriptional profiles to predict aging and construct aging specific cross-tissue networks
    Yin Wang, Tao Huang, Lu Xie, Lei Liu
    BMC Systems Biology.2016;[Epub]     CrossRef
  • Management of pancreatic cancer in the elderly
    Oliver Higuera
    World Journal of Gastroenterology.2016; 22(2): 764.     CrossRef
  • UBTD1 induces cellular senescence through an UBTD1-Mdm2/p53 positive feedback loop
    Xiao-Wei Zhang, Xiao-Feng Wang, Su-Jie Ni, Wei Qin, Li-Qin Zhao, Rui-Xi Hua, You-Wei Lu, Jin Li, Goberdhan P Dimri, Wei-Jian Guo
    The Journal of Pathology.2015; 235(4): 656.     CrossRef
  • Biomolecular bases of the senescence process and cancer. A new approach to oncological treatment linked to ageing
    Iker Badiola, Francisco Santaolalla, Patricia Garcia-Gallastegui, Sánchez-del Rey Ana, Fernando Unda, Gaskon Ibarretxe
    Ageing Research Reviews.2015; 23: 125.     CrossRef
  • Sensitization of U937 leukemia cells to doxorubicin by the MG132 proteasome inhibitor induces an increase in apoptosis by suppressing NF-kappa B and mitochondrial membrane potential loss
    Pablo César Ortiz-Lazareno, Alejandro Bravo-Cuellar, José Manuel Lerma-Díaz, Luis Felipe Jave-Suárez, Adriana Aguilar-Lemarroy, Jorge Ramiro Domínguez-Rodríguez, Oscar González-Ramella, Ruth De Célis, Paulina Gómez-Lomelí, Georgina Hernández-Flores
    Cancer Cell International.2014;[Epub]     CrossRef
  • Induction of DNA damage and p21-dependent senescence by Riccardin D is a novel mechanism contributing to its growth suppression in prostate cancer cells in vitro and in vivo
    Zhongyi Hu, Denglu Zhang, Jianrong Hao, Keli Tian, Wei Wang, Hongxiang Lou, Huiqing Yuan
    Cancer Chemotherapy and Pharmacology.2014; 73(2): 397.     CrossRef
  • Genome-Wide Transcriptional Reorganization Associated with Senescence-to-Immortality Switch during Human Hepatocellular Carcinogenesis
    Gokhan Yildiz, Ayca Arslan-Ergul, Sevgi Bagislar, Ozlen Konu, Haluk Yuzugullu, Ozge Gursoy-Yuzugullu, Nuri Ozturk, Cigdem Ozen, Hilal Ozdag, Esra Erdal, Sedat Karademir, Ozgul Sagol, Dilsa Mizrak, Hakan Bozkaya, Hakki Gokhan Ilk, Ozlem Ilk, Biter Bilen, R
    PLoS ONE.2013; 8(5): e64016.     CrossRef
  • Telomerase- and angiogenesis-related gene responses to irradiation in human umbilical vein endothelial cells
    HYUN CHANG, SUN YOUNG RHA, HEI-CHEUL JEUNG, KYU HYUN PARK, TAE SOO KIM, YONG-BAE KIM, HYUN CHEOL CHUNG
    International Journal of Molecular Medicine.2013; 31(5): 1202.     CrossRef
  • Malglycemia and Cancer: Introduction to a Conceptual Model
    Marilyn J. Hammer, Joachim G. Voss
    Oncology Nursing Forum.2012; 39(3): E275.     CrossRef
  • Human Xp/Yp telomere analysis by Southern-STELA
    Milena Ivanković, Andrea Ćukušić Kalajžić, Nikolina Škrobot Vidaček, Ivana Franić Šimić, Sanja Davidović Mrsić, Ivica Rubelj
    Biogerontology.2012; 13(2): 203.     CrossRef
  • Lithocholic bile acid selectively kills neuroblastoma cells, while sparing normal neuronal cells
    Alexander A. Goldberg, Adam Beach, Gerald F. Davies, Troy A. A. Harkness, Andréa LeBlanc, Vladimir I. Titorenko
    Oncotarget.2011; 2(10): 761.     CrossRef
  • New biomarkers probing depth of cell senescence assessed by laser scanning cytometry
    Hong Zhao, H. Dorota Halicka, Frank Traganos, Ellen Jorgensen, Zbigniew Darzynkiewicz
    Cytometry Part A.2010; 77A(11): 999.     CrossRef
  • The ATM Cofactor ATMIN Protects against Oxidative Stress and Accumulation of DNA Damage in the Aging Brain
    Nnennaya Kanu, Kay Penicud, Mariya Hristova, Barnaby Wong, Elaine Irvine, Florian Plattner, Gennadij Raivich, Axel Behrens
    Journal of Biological Chemistry.2010; 285(49): 38534.     CrossRef
  • 11,404 View
  • 77 Download
  • 33 Crossref
Close layer
Original Articles
Docetaxel versus Paclitaxel Combined with 5-FU and Leucovorin in Advanced Gastric Cancer: Combined Analysis of Two Phase II Trials
Hong Jae Chon, Sun Young Rha, Chong Kun Im, Chan Kim, Min Hee Hong, Hye Ryun Kim, Jung Ryun An, Sung Hoon Noh, Hyun Cheol Chung, Hei-Cheul Jeung
Cancer Res Treat. 2009;41(4):196-204.   Published online December 31, 2009
DOI: https://doi.org/10.4143/crt.2009.41.4.196
AbstractAbstract PDFPubReaderePub
Purpose

This is an ad hoc analysis of two phase II studies which compared the efficacy and safety of two taxanes (paclitaxel and docetaxel) combined with 5-fluorouracil (5-FU) and leucovorin (LV) in advanced gastric cancer.

Materials and Methods

Patients with advanced gastric adenocarcinoma who were untreated or had only received first-line chemotherapy, were treated with either paclitaxel (PFL; 175 mg/m2) or docetaxel (DFL; 75 mg/m2) on day 1, followed by a bolus of LV (20 mg/m2 days 1~3) and a 24-hour infusion of 5-FU (1,000 mg/m2 days 1~3) every 3 weeks. The primary endpoint was overall response rate (ORR) and the secondary endpoint included survival and toxicity.

Results

Sixty-six patients received DFL (first-line [n=38]; and second-line [n=28]) and 60 patients received PFL (first-line [n=37]; and second-line [n=23]). The ORRs were not significantly different between the 2 groups (DFL, 26%; PFL, 38%). With a median follow-up of 9.5 months, the progression free survival was 5.2 months (95% confidence interval [CI], 4.2~6.5 months) for DFL and 3.3 months (95% CI, 1.3~5.5 months) for PFL (p=0.17). The overall survival was also comparable between the patients who received DFL and PFL (10.0 months [95% CI, 7.2~12.5 months] and 13.9 months [95% CI, 10.9~19.2 months], respectively; p=0.37). The most frequent grade 3~4 adverse event was neutropenia (DFL, 71%; PFL, 62%). DFL and PFL had different non-hematologic toxicities; specifically, grade ≥3 mucositis (5%) and diarrhea (3%) were common in DFL, while nausea/vomiting (15%) and peripheral neuropathy (5%) were common in PFL.

Conclusion

Thus, the two taxanes had similar efficacy in the treatment of advanced gastric cancer, but different toxicity profiles. Prospective comparative studies are required to further clarify the role of taxanes in the treatment of advanced gastric cancer.

Citations

Citations to this article as recorded by  
  • Drug-Induced Peripheral Neuropathy: Diagnosis and Management
    Diala Merheb, Georgette Dib, Maroun Bou Zerdan, Clara El Nakib, Saada Alame, Hazem I. Assi
    Current Cancer Drug Targets.2022; 22(1): 49.     CrossRef
  • Treatment Outcome and Safety of the TCX Regimen for Advanced Gastric Cancer: A Prospective Cohort Study
    Hieu Trong Nguyen, Kien Hung Do, Nguyen Ba Le, Thang Tran
    Cancer Management and Research.2022; Volume 14: 2825.     CrossRef
  • Role for Drug Transporters in Chemotherapy‐Induced Peripheral Neuropathy
    Tore B. Stage, Shuiying Hu, Alex Sparreboom, Deanna L. Kroetz
    Clinical and Translational Science.2021; 14(2): 460.     CrossRef
  • Personalized Antibodies for Gastroesophageal Adenocarcinoma (PANGEA): A Phase II Study Evaluating an Individualized Treatment Strategy for Metastatic Disease
    Daniel V.T. Catenacci, Stephanie Moya, Samantha Lomnicki, Leah M. Chase, Bryan F. Peterson, Natalie Reizine, Lindsay Alpert, Namrata Setia, Shu-Yuan Xiao, John Hart, Uzma D. Siddiqui, D. Kyle Hogarth, Oliver S. Eng, Kiran Turaga, Kevin Roggin, Mitchell C.
    Cancer Discovery.2021; 11(2): 308.     CrossRef
  • Neuroinflammatory Process Involved in Different Preclinical Models of Chemotherapy-Induced Peripheral Neuropathy
    Giulia Fumagalli, Laura Monza, Guido Cavaletti, Roberta Rigolio, Cristina Meregalli
    Frontiers in Immunology.2021;[Epub]     CrossRef
  • Pathogenesis of paclitaxel-induced peripheral neuropathy: A current review of in vitro and in vivo findings using rodent and human model systems
    Nathan P. Staff, Jill C. Fehrenbacher, Martial Caillaud, M. Imad Damaj, Rosalind A. Segal, Sandra Rieger
    Experimental Neurology.2020; 324: 113121.     CrossRef
  • Salvage systemic therapy for advanced gastric and oesophago-gastric junction adenocarcinoma
    Yoko Tomita, Max Moldovan, Rachael Chang Lee, Amy HC Hsieh, Amanda Townsend, Timothy Price
    Cochrane Database of Systematic Reviews.2020;[Epub]     CrossRef
  • Paclitaxel, 5-fluorouracil, and leucovorin combination chemotherapy as first-line treatment in patients with advanced gastric cancer
    Wan-Cai Que, Yan-Fang Huang, Xiao-Yan Lin, Yan-Qin Lan, Xin-Yan Gao, Xin-Li Wang, Ri-Ping Wu, Bin Du, Xiao-Bin Huang, Hong-qiang Qiu, Dong-Ta Zhong
    Anti-Cancer Drugs.2019; 30(3): 302.     CrossRef
  • Randomised phase II trial comparing four front-line doublets in Asian patients with metastatic gastric cancer
    Chan Kim, Hong Jae Chon, Joo Hoon Kim, Minkyu Jung, Chung Mo Nam, Hyo Song Kim, Beodeul Kang, Hyun Cheol Chung, Sun Young Rha
    European Journal of Cancer.2019; 112: 20.     CrossRef
  • Trastuzumab emtansine versus taxane use for previously treated HER2-positive locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma (GATSBY): an international randomised, open-label, adaptive, phase 2/3 study
    Peter C Thuss-Patience, Manish A Shah, Atsushi Ohtsu, Eric Van Cutsem, Jaffer A Ajani, Hugo Castro, Wasat Mansoor, Hyun Cheol Chung, Gyorgy Bodoky, Kohei Shitara, Gail D Lewis Phillips, Tina van der Horst, Marie-Laurence Harle-Yge, Betsy L Althaus, Yoon-K
    The Lancet Oncology.2017; 18(5): 640.     CrossRef
  • Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy
    Hana Starobova, Irina Vetter
    Frontiers in Molecular Neuroscience.2017;[Epub]     CrossRef
  • Identifying therapeutic targets in gastric cancer: the current status and future direction
    Beiqin Yu, Jingwu Xie
    Acta Biochimica et Biophysica Sinica.2016; 48(1): 90.     CrossRef
  • Role of Transient Receptor Potential Channels in Paclitaxel- and Oxaliplatin-induced Peripheral Neuropathy
    Kyoji Taguchi
    YAKUGAKU ZASSHI.2016; 136(2): 287.     CrossRef
  • Paclitaxel combined with oxaliplatin as first-line chemotherapy for locally advanced or metastatic gastric cancer
    Chunmei Shi, Qiang Chen, Songfei Shen, Riping Wu, Baoyu Yang, Qing Liu, Qian Xu
    Expert Review of Anticancer Therapy.2015; 15(5): 595.     CrossRef
  • Corosolic acid enhances 5-fluorouracil-induced apoptosis against SNU-620 human gastric carcinoma cells by inhibition of mammalian target of rapamycin
    HYUN SU LEE, JUN BEOM PARK, MYUNG SUN LEE, EUN YOUNG CHA, JI YEON KIM, JI YOUNG SUL
    Molecular Medicine Reports.2015; 12(3): 4782.     CrossRef
  • Paclitaxel-based regimens as first-line treatment in advanced gastric cancer
    Zengqing Guo, Xiaojie Wang, Rongbo Lin, Ling Chen, Nanfeng Fan, Yu Chen, Jinyuan Lin, Jiami Yu
    Journal of Chemotherapy.2015; 27(2): 94.     CrossRef
  • A phase 2 study of fluorouracil/leucovorin in combination with paclitaxel and oxaliplatin as a salvage treatment in patients with refractory or relapsed advanced gastric cancer
    Rongbo Lin, Nanfeng Fan, Guangfeng Wu, Ying Chen, Zengqing Guo, Xiaojie Wang, Feng Jin, Ling Chen, Jie Liu
    Journal of Chemotherapy.2015; 27(1): 52.     CrossRef
  • Paclitaxel combined with capecitabine as first-line chemotherapy for advanced or recurrent gastric cancer
    MEIQIN YUAN, YUNSHAN YANG, WANGXIA LV, ZHENGBO SONG, HAIJUN ZHONG
    Oncology Letters.2014; 8(1): 351.     CrossRef
  • Chemotherapy-induced peripheral neurotoxicity (CIPN): An update
    Andreas A. Argyriou, Jordi Bruna, Paola Marmiroli, Guido Cavaletti
    Critical Reviews in Oncology/Hematology.2012; 82(1): 51.     CrossRef
  • Peripheral neuropathies from chemotherapeutics and targeted agents: diagnosis, treatment, and prevention
    W. Grisold, G. Cavaletti, A. J. Windebank
    Neuro-Oncology.2012; 14(suppl 4): iv45.     CrossRef
  • Successful Treatment of a Patient with HER2-Positive Metastatic Gastric Cancer with Third-Line Combination Therapy with Irinotecan, 5-Fluorouracil, Leucovorin and Trastuzumab (FOLFIRI-T)
    Florian Weissinger, Marc Reymond, Klaus Dumke, Martin Krüger
    Onkologie.2011; 34(10): 548.     CrossRef
  • RAD001 shows activity against gastric cancer cells and overcomes 5-FU resistance by downregulating thymidylate synthase
    Kyung-Hun Lee, Hyung-Seok Hur, Seock-Ah Im, Juhee Lee, Hwang-Phill Kim, Young-Kwang Yoon, Sae-Won Han, Sang-Hyun Song, Do-Youn Oh, Tae-You Kim, Yung-Jue Bang
    Cancer Letters.2010; 299(1): 22.     CrossRef
  • 12,310 View
  • 76 Download
  • 22 Crossref
Close layer
Biopsy Related Prostate Status Does Not Affect on the Clinicopathological Outcome of Robotic Assisted Laparoscopic Radical Prostatectomy
Hoon Choi, Young Hwii Ko, Sung Gu Kang, Seok Ho Kang, Hong Seok Park, Jun Cheon, Vipul R. Patel
Cancer Res Treat. 2009;41(4):205-210.   Published online December 31, 2009
DOI: https://doi.org/10.4143/crt.2009.41.4.205
AbstractAbstract PDFPubReaderePub
Purpose

To determine whether the biopsy core number and time interval between prostate biopsy and radical prostatectomy affect the operative and oncologic outcome of robot assisted laparoscopic radical prostatectomy (RALP).

Materials and Methods

From January 2008 to April 2009, a single surgeon performed 72 RALPs after an initial learning period of 30 cases. The relationship between time from biopsy to prostatectomy and biopsy core number with operative time and estimated blood loss (EBL) were initially evaluated with a linear regression model. These patients were classified into groups according to whether the interval from biopsy to RALP was within four weeks or not, and whether there were less than or greater than 10 core specimens removed.

Results

RALP was performed in 34 patients within four weeks of biopsy, and in 38 patients more than 4 weeks after biopsy. According to the number of core specimens removed, less than 10 cores were performed in 10 patients, and more than 10 cores were performed in 62 patients. Using an interval of 4 weeks as the cutoff point, early surgery was associated with longer operating time (232.6 vs 208.8 min) and increased estimated blood loss (305.1 vs 276.9 mL). For cases with more than 10 biopsy cores, there was a slight increase in operative time (229.2 vs 210.3 min). None of these differences were statistically significant by multivariate analysis.

Conclusion

Our data suggests that there is no reason to delay RALP to more than 4 weeks after prostate biopsy. It also revealed that the number of biopsy cores (up to 14) did not influence operative outcome. Thus, RALP is a feasible procedure regardless of the biopsy related prostate state.

Citations

Citations to this article as recorded by  
  • Effect of Transperineal Versus Transrectal Prostate Biopsy on the Quality of Hydrogel Spacer Placement in Men Prior to Radiation Therapy for Prostate Cancer
    Michael E. Rezaee, Ulysses Gardner, Mark N. Alshak, Stephen C. Greco, Daniel Y. Song, Michael Goldstein, Christian P. Pavlovich
    Urology.2023; 182: 27.     CrossRef
  • Does time interval between prostate biopsy and surgery affect outcomes of radical prostatectomy? A systematic review and meta-analysis
    Jie Li, Qing Jiang, Qiubo Li, Yuanfeng Zhang, Liang Gao
    International Urology and Nephrology.2020; 52(4): 619.     CrossRef
  • Short interval of biopsy to robotic-assisted laparoscopic radical prostatectomy does not render any adverse effects on the perioperative outcomes
    Minke He, Yaohui Li, Zhuoyi Xiang, Li-an Sun, Yanjun Zhu, Xiaoyi Hu, Jianming Guo, Hang Wang
    Medicine.2018; 97(36): e11686.     CrossRef
  • A Multidimensional Analysis of Prostate Surgery Costs in the United States: Robotic-Assisted versus Retropubic Radical Prostatectomy
    Akash Bijlani, April E. Hebert, Mike Davitian, Holly May, Mark Speers, Robert Leung, Nihal E. Mohamed, Henry S. Sacks, Ashutosh Tewari
    Value in Health.2016; 19(4): 391.     CrossRef
  • Interval from Prostate Biopsy to Radical Prostatectomy Does Not Affect Immediate Operative Outcomes for Open or Minimally Invasive Approach
    Bumsoo Park, Seol Ho Choo, Hwang Gyun Jeon, Byong Chang Jeong, Seong Il Seo, Seong Soo Jeon, Hyun Moo Lee, Han Yong Choi
    Journal of Korean Medical Science.2014; 29(12): 1688.     CrossRef
  • Interval from Prostate Biopsy to Robot-Assisted Laparoscopic Radical Prostatectomy (RALP): Effects on Surgical Difficulties
    In Sung Kim, Woong Na, Jung Su Nam, Jong Jin Oh, Chang Wook Jeong, Sung Kyu Hong, Seok Soo Byun, Sang Eun Lee
    Korean Journal of Urology.2011; 52(10): 664.     CrossRef
  • Prostate-Specific Antigen Density as a Powerful Predictor of Extracapsular Extension and Positive Surgical Margin in Radical Prostatectomy Patients with Prostate-Specific Antigen Levels of Less than 10 ng/ml
    Jin-Seok Chang, Hoon Choi, Young-Seop Chang, Jin-Bum Kim, Mi Mi Oh, Du Geon Moon, Jae Hyun Bae, Jun Cheon
    Korean Journal of Urology.2011; 52(12): 809.     CrossRef
  • 9,620 View
  • 51 Download
  • 7 Crossref
Close layer
No Association between Promoter Polymorphism of STK11 Gene and Lung Cancer Risk in the Korean Population
Jae Sook Sung, Young Mi Whang, Kyong Hwa Park, Jeong-Seon Ryu, Jong Gwon Choi, Jae Hong Seo, Sang Won Shin, Jun Suk Kim, Yeul Hong Kim
Cancer Res Treat. 2009;41(4):211-217.   Published online December 31, 2009
DOI: https://doi.org/10.4143/crt.2009.41.4.211
AbstractAbstract PDFPubReaderePub
Purpose

Serine-threonine kinase11 (STK11) was originally identified in 1997 as the causative mutation that's responsible for Peutz-Jeghers Syndrome (PJS). Several recent studies have reported that the STK11 gene is an important human tumor suppressor gene in lung cancer. We evaluated the associations between the polymorphisms of the STK11 promoter region and the risk of lung cancer in 901 Koreans.

Materials and Methods

By direct sequencing, we first discovered three novel polymorphisms (-1,795 T>C, -981 C>T and -160 G>T) and four known polymorphisms (-1,580 C>T, -1,494 A>C, -881 A>G and -458 G>C) of the STK11 promoter region in 24 blood samples of 24 Korean lung cancer patients. Further genotype analyses were then performed on 443 lung cancer patients and 458 controls.

Results

We discovered three novel polymorphisms and we identified four known polymorphisms of the STK11 promoter region in a Korean population. Statistical analyses revealed that the genotypes and haplotypes in the STK11 gene were not significantly associated with the risk of lung cancer in a Korean population.

Conclusion

This is the first study that's focused on the association of STK11 promoter polymorphisms and the risk of lung cancer in a Korean population. To evaluate the role of the STK11 gene for the risk of lung cancer, the genotypes of the STK11 promoter region (-1,795 T>C, -1,494 A>C and -160 G>T) were determined in 901 Koreans, yet the result revealed no significant difference between the lung cancer patients and the controls. These results suggest that the three promoter polymorphisms we studied are not important risk factors for the susceptibility to lung cancer in Koreans.

Citations

Citations to this article as recorded by  
  • A polymorphic minisatellite region of BORIS regulates gene expression and its rare variants correlate with lung cancer susceptibility
    Se-Lyun Yoon, Yun-Gil Roh, In-Sun Chu, Jeonghoon Heo, Seung Il Kim, Heekyung Chang, Tae-Hong Kang, Jin Woong Chung, Sang Seok Koh, Vladimir Larionov, Sun-Hee Leem
    Experimental & Molecular Medicine.2016; 48(7): e246.     CrossRef
  • Integrated Analysis of Transcriptomes of Cancer Cell Lines and Patient Samples Reveals STK11/LKB1–Driven Regulation of cAMP Phosphodiesterase-4D
    Ningning He, Nayoung Kim, Mee Song, Choa Park, Somin Kim, Eun Young Park, Hwa Young Yim, Kyunga Kim, Jong Hoon Park, Keun Il Kim, Fan Zhang, Gordon B. Mills, Sukjoon Yoon
    Molecular Cancer Therapeutics.2014; 13(10): 2463.     CrossRef
  • Hot embossed polyethylene through-hole chips for bead-based microfluidicdevices
    Jie Chou, Nan Du, Tina Ou, Pierre N. Floriano, Nicolaos Christodoulides, John T. McDevitt
    Biosensors and Bioelectronics.2013; 42: 653.     CrossRef
  • Discovery and Evaluation of Polymorphisms in theAKT2andAKT3Promoter Regions for Risk of Korean Lung Cancer
    Jae Sook Sung, Kyong Hwa Park, Seung Tae Kim, Yeul Hong Kim
    Genomics & Informatics.2012; 10(3): 167.     CrossRef
  • 10,474 View
  • 49 Download
  • 4 Crossref
Close layer
No Association of Vascular Endothelial Growth Factor-A (VEGF-A) and VEGF-C Expression with Survival in Patients with Gastric Cancer
Soo Jung Lee, Jong Gwang Kim, Sang Kyun Sohn, Yee Soo Chae, Joon Ho Moon, Shi Nae Kim, Han-Ik Bae, Ho Young Chung, Wansik Yu
Cancer Res Treat. 2009;41(4):218-223.   Published online December 31, 2009
DOI: https://doi.org/10.4143/crt.2009.41.4.218
AbstractAbstract PDFPubReaderePub
Purpose

Although the vascular endothelial growth factor (VEGF) superfamily has been identified to critically influence tumor-related angiogenesis, the prognostic significance of a VEGF expression in gastric cancer is still controversial. Accordingly, the present study analyzed the VEGF-A and VEGF-C expressions and their impact on the prognosis of patients with gastric cancer.

Materials and Methods

Three hundred seventy-five consecutive patients who underwent surgical resection for gastric adenocarcinoma with a curative intent were enrolled in the present study. Immunohistochemical staining for VEGF-A and VEGF-C was performed using the formalin fixed, paraffin embedded tumor tissues.

Results

Positive VEGF-A and VEGF-C expressions were observed in 337 (90.1%) and 278 (74.9%) cases, respectively. The survival analysis showed that the expression of VEGF-A and VEGF-C had no effect on the OS and DFS. On the multivariate analysis that included age, gender and the TNM stage, no significant association between the grade of the VEGF-A or VEGF-C expression and survival was observed.

Conclusion

The current study suggests that the tissue expression of VEGF-A or VEGF-C alone is not an independent prognostic marker for patients with surgically resected gastric adenocarcinoma.

Citations

Citations to this article as recorded by  
  • Proposed Molecular and miRNA Classification of Gastric Cancer
    Lara Alessandrini, Melissa Manchi, Valli De Re, Riccardo Dolcetti, Vincenzo Canzonieri
    International Journal of Molecular Sciences.2018; 19(6): 1683.     CrossRef
  • Biomarker analyses in REGARD gastric/GEJ carcinoma patients treated with VEGFR2-targeted antibody ramucirumab
    Charles S Fuchs, Josep Tabernero, Jiří Tomášek, Ian Chau, Bohuslav Melichar, Howard Safran, Mustapha A Tehfe, Dumitru Filip, Eldar Topuzov, Luis Schlittler, Anghel Adrian Udrea, William Campbell, Stephen Brincat, Michael Emig, Symantha A Melemed, Rebecca
    British Journal of Cancer.2016; 115(8): 974.     CrossRef
  • Fentanyl inhibits the progression of human gastric carcinoma MGC-803 cells by modulating NF-κB-dependent gene expression in vivo
    GUODONG HE, LI LI, ENJIAN GUAN, JING CHEN, YI QIN, YUBO XIE
    Oncology Letters.2016; 12(1): 563.     CrossRef
  • Disrupted Balance of MMPs/TIMPs in Gastric Carcinogenesis–Paradoxical Low MMP-2 Expression in Tumor and Stromal Compartments as a Potential Marker of Unfavorable Outcome
    Piotr Donizy, Julia Rudno-Rudzinska, Maciej Kaczorowski, Jedrzej Kabarowski, Ewelina Frejlich, Wojciech Kielan, Rafal Matkowski, Agnieszka Halon
    Cancer Investigation.2015; 33(7): 286.     CrossRef
  • The different role of intratumoral and peritumoral lymphangiogenesis in gastric cancer progression and prognosis
    Kyung Ho Pak, Ara Jo, Hye Ji Choi, Younghee Choi, Hyunki Kim, Jae-Ho Cheong
    BMC Cancer.2015;[Epub]     CrossRef
  • Molecular classification of gastric cancer: Towards a pathway-driven targeted therapy
    Ismael Riquelme, Kathleen Saavedra, Jaime A. Espinoza, Helga Weber, Patricia García, Bruno Nervi, Marcelo Garrido, Alejandro H. Corvalán, Juan Carlos Roa, Carolina Bizama
    Oncotarget.2015; 6(28): 24750.     CrossRef
  • VEGF-C expression is associated with the poor survival in gastric cancer tissue
    Weiguo Cao, Rong Fan, Weiping Yang, Yunlin Wu
    Tumor Biology.2014; 35(4): 3377.     CrossRef
  • VEGF-A clinical significance in gastric cancers: Immunohistochemical analysis of a wide Italian cohort
    E. Lastraioli, L. Boni, M.R. Romoli, S. Crescioli, A. Taddei, S. Beghelli, A. Tomezzoli, C. Vindigni, L. Saragoni, L. Messerini, M. Bernini, L. Bencini, E. Giommoni, G. Freschi, F. Di Costanzo, A. Scarpa, P. Morgagni, M. Farsi, F. Roviello, G. De Manzoni,
    European Journal of Surgical Oncology (EJSO).2014; 40(10): 1291.     CrossRef
  • Prognostic value of vascular endothelial growth factor A expression in gastric cancer: a meta-analysis
    Ya-nan Ji, Qin Wang, Yang Li, Zhi Wang
    Tumor Biology.2014; 35(3): 2787.     CrossRef
  • Clinicopathologic Significance of Nuclear Factor-κB and Vascular Endothelial Growth Factor Expression in Advanced Gastric Cancer Patients
    Keon Woo Park, Su-Jin Kim, Sung Yong Oh
    Oncology Research and Treatment.2014; 37(4): 183.     CrossRef
  • Prognostic Value of Vascular Endothelial Growth Factor Expression in Resected Gastric Cancer
    Lei Liu, Xue-Lei Ma, Zhi-Lan Xiao, Mei Li, Si-Hang Cheng, Yu-Quan Wei
    Asian Pacific Journal of Cancer Prevention.2012; 13(7): 3089.     CrossRef
  • Potential prognostic and therapeutic role for angiogenesis markers in laryngeal carcinoma
    Marco Lionello, Alberto Staffieri, Gino Marioni
    Acta Oto-Laryngologica.2012; 132(6): 574.     CrossRef
  • Prognostic significance of vascular endothelial growth factor immunohistochemical expression in gastric cancer: a meta-analysis
    Ling Peng, Ping Zhan, Yun Zhou, Weijia Fang, Peng Zhao, Yulong Zheng, Nong Xu
    Molecular Biology Reports.2012; 39(10): 9473.     CrossRef
  • Protein Kinase B Phosphorylation Correlates with Vascular Endothelial Growth Factor A and Microvessel Density in Gastric Adenocarcinoma
    Xd Zhou, Hx Chen, Rn Guan, Yp Lei, X Shu, Y Zhu, Nh Lv
    Journal of International Medical Research.2012; 40(6): 2124.     CrossRef
  • Prognostic significance of vascular endothelial growth factor expression in gastric carcinoma: a meta-analysis
    Jing Chen, Tao Li, Yuanyuan Wu, Lijun He, Li Zhang, Tieliu Shi, Zhengfang Yi, Mingyao Liu, Xiufeng Pang
    Journal of Cancer Research and Clinical Oncology.2011; 137(12): 1799.     CrossRef
  • Vascularization of testicular germ cell tumours: evidence from experimental teratocarcinomas
    U. Silván, A. Díez‐Torre, L. Jiménez‐Rojo, J. Aréchaga
    International Journal of Andrology.2010; 33(6): 765.     CrossRef
  • Cancer-associated fibroblasts are positively correlated with metastatic potential of human gastric cancers
    Kangkang Zhi, Xiaojun Shen, Hao Zhang, Jianwei Bi
    Journal of Experimental & Clinical Cancer Research.2010;[Epub]     CrossRef
  • 10,759 View
  • 66 Download
  • 17 Crossref
Close layer
Mutational Analysis of TTK Gene in Gastric and Colorectal Cancers with Microsatellite Instability
Chang Hyeok Ahn, Yoo Ri Kim, Sung Soo Kim, Nam Jin Yoo, Sug Hyung Lee
Cancer Res Treat. 2009;41(4):224-228.   Published online December 31, 2009
DOI: https://doi.org/10.4143/crt.2009.41.4.224
AbstractAbstract PDFPubReaderePub
Purpose

The TTK gene plays a crucial role in regulation of the mitotic checkpoint. The TTK gene has an A9 mononucleotide repeat in the coding sequences, which harbors mutations in gastric (GC) and colorectal cancers (CRC) with microsatellite instability (MSI). However, there are three more repeats (the A7s) in the coding sequences that have not been analyzed. The aim of this study was to explore whether the three A7s as well as the A9 are altered in GC and CRC, and to find any association of TTK mutation with clinocopathologic characteristics of GC and CRC.

Materials and Methods

We analyzed exon 5 (A7 and A7) and exon 22 (A9 and A7) which have repeat sequences in 30 GC with high MSI (MSI-H), 15 GC with low MSI (MSI-L), 35 CRC with MSI-H, and 15 CRC with MSI-L, by single-strand conformation polymorphism (SSCP) and DNA sequencing assays.

Results

Overall, we detected 23 frameshift mutations in the repeat sequences of TTK in the GC with MSI-H (11/30; 36.7%) and the CRC with MSI-H (12/35; 34.3%), but not in the cancers with MSI-L. The mutations were observed in both A9 and A7 of exon 22, but in neither of the two A7s of exon 5. The mutations consisted of c.2560delA, c.2560dupA, c.2571delA and c.[2560delA(+)2571delA]. All of the mutations were frameshift mutations and would result in premature stops of TTK protein synthesis. There was no significant difference in clinopathologic parameters of the cancers with the mutations.

Conclusion

Our data indicate that frameshift mutations of TTK are common in both GC and CRC with MSI-H, and that the mutations occur not only in the A9 repeat but also in the A7 repeat. The data suggest that frameshift mutations of TTK might alter cell cycle control in the affected cells and contribute to pathogenesis of cancers with MSI-H.

Citations

Citations to this article as recorded by  
  • Uncovering the underlying mechanism of yuanhuacine against colorectal cancer by transcriptomics and experimental investigations
    Jingchu Li, Shanshan Liu, Jian Chen, Hanxue Wang, Xia Feng, Chenglin Jia, Jiacheng Li, Hao Yin, Jie Li, Chang Liu, Yongbing Cao, Chao Ma
    Phytomedicine.2025; 140: 156570.     CrossRef
  • Identification of Unique Long Non-Coding RNAs as Putative Biomarkers for Chromophobe Renal Cell Carcinoma
    Guanlin Wu, Pengfei Xia, Shixian Yan, Dongming Chen, Lei Xie, Gang Fan
    Personalized Medicine.2021; 18(1): 9.     CrossRef
  • In-Silico Evaluation of Genetic Alterations in Ovarian Carcinoma and Therapeutic Efficacy of NSC777201, as a Novel Multi-Target Agent for TTK, NEK2, and CDK1
    Harshita Nivrutti Khedkar, Yu-Chi Wang, Vijesh Kumar Yadav, Prateeti Srivastava, Bashir Lawal, Ntlotlang Mokgautsi, Maryam Rachmawati Sumitra, Alexander T. H. Wu, Hsu-Shan Huang
    International Journal of Molecular Sciences.2021; 22(11): 5895.     CrossRef
  • Reversine inhibits proliferation, invasion and migration and induces cell apoptosis in gastric cancer cells by downregulating TTK
    Pengfei Xia, Jin Liang, Di Jin, Zhanyong Jin
    Experimental and Therapeutic Medicine.2021;[Epub]     CrossRef
  • Characteristic Analysis of Featured Genes Associated With Stemness Indices in Colorectal Cancer
    Yongqu Lu, Xin Zhou, Zhenzhen Liu, Wendong Wang, Fei Li, Wei Fu
    Frontiers in Molecular Biosciences.2020;[Epub]     CrossRef
  • Mutations Defining Patient Cohorts With Elevated PD-L1 Expression in Gastric Cancer
    Otília Menyhárt, Lőrinc Sándor Pongor, Balázs Győrffy
    Frontiers in Pharmacology.2019;[Epub]     CrossRef
  • Comprehensive Analysis of Mouse Cancer/Testis Antigen Functions in Cancer Cells and Roles of TEKT5 in Cancer Cells and Testicular Germ Cells
    Nana Aoki, Yasuhisa Matsui
    Molecular and Cellular Biology.2019;[Epub]     CrossRef
  • TTK promotes mesenchymal signaling via multiple mechanisms in triple negative breast cancer
    Jamie L. King, Baotong Zhang, Yixiang Li, Kathy P. Li, Jianping J. Ni, Harold I. Saavedra, Jin-Tang Dong
    Oncogenesis.2018;[Epub]     CrossRef
  • ABCB1 2677G>T/A variant enhances chemosensitivity to anti-cancer agents acting on microtubule dynamics through LAMP1 inhibition
    Woo Sun Kwon, Sun Young Rha, Hei-Cheul Jeung, Joong Bae Ahn, Jae-Joon Jung, Dong Hyuk Ki, Tae Soo Kim, Hyun Cheol Chung
    Biochemical Pharmacology.2017; 123: 73.     CrossRef
  • Threonine and tyrosine kinase may serve as a prognostic biomarker for gallbladder cancer
    Yuan Xie, Jian-Zhen Lin, An-Qiang Wang, Wei-Yu Xu, Jun-Yu Long, Yu-Feng Luo, Jie Shi, Zhi-Yong Liang, Xin-Ting Sang, Hai-Tao Zhao
    World Journal of Gastroenterology.2017; 23(31): 5787.     CrossRef
  • Multiple siRNA delivery against cell cycle and anti-apoptosis proteins using lipid-substituted polyethylenimine in triple-negative breast cancer and nonmalignant cells
    Manoj B. Parmar, Bárbara E. Arteaga Ballesteros, Timothy Fu, Remant Bahadur K.C., Hamidreza Montazeri Aliabadi, Judith C. Hugh, Raimar Löbenberg, Hasan Uludağ
    Journal of Biomedical Materials Research Part A.2016; 104(12): 3031.     CrossRef
  • Novel Mps1 Kinase Inhibitors with Potent Antitumor Activity
    Antje M. Wengner, Gerhard Siemeister, Marcus Koppitz, Volker Schulze, Dirk Kosemund, Ulrich Klar, Detlef Stoeckigt, Roland Neuhaus, Philip Lienau, Benjamin Bader, Stefan Prechtl, Marian Raschke, Anna-Lena Frisk, Oliver von Ahsen, Martin Michels, Bertolt K
    Molecular Cancer Therapeutics.2016; 15(4): 583.     CrossRef
  • Microsatellite instability detected in tumor-related genes in C57BL/6J mice with thymic lymphoma induced by N -methyl- N -nitrosourea
    Shuangyue Zhang, Xueyun Huo, Zhenkun Li, Xiaohong Li, Wang Tang, Changlong Li, Meng Guo, Xiaoyan Du, Zhenwen Chen
    Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis.2015; 782: 7.     CrossRef
  • Ataxia‐telangiectasia‐mutated protein expression with microsatellite instability in gastric cancer as prognostic marker
    Jin Won Kim, Seock‐Ah Im, Min A Kim, Hyun Jin Cho, Dae Won Lee, Kyung‐Hun Lee, Tae‐Yong Kim, Sae‐Won Han, Do‐Youn Oh, Hyuk‐Joon Lee, Tae‐You Kim, Han‐Kwang Yang, Woo Ho Kim, Yung‐Jue Bang
    International Journal of Cancer.2014; 134(1): 72.     CrossRef
  • Mitosis as an anti-cancer drug target
    Anna-Leena Salmela, Marko J. Kallio
    Chromosoma.2013; 122(5): 431.     CrossRef
  • The MPS1 Family of Protein Kinases
    Xuedong Liu, Mark Winey
    Annual Review of Biochemistry.2012; 81(1): 561.     CrossRef
  • Meta-analysis of gene expression microarrays with missing replicates
    Fan Shi, Gad Abraham, Christopher Leckie, Izhak Haviv, Adam Kowalczyk
    BMC Bioinformatics.2011;[Epub]     CrossRef
  • Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer
    Kai Wang, Junsuo Kan, Siu Tsan Yuen, Stephanie T Shi, Kent Man Chu, Simon Law, Tsun Leung Chan, Zhengyan Kan, Annie S Y Chan, Wai Yin Tsui, Siu Po Lee, Siu Lun Ho, Anthony K W Chan, Grace H W Cheng, Peter C Roberts, Paul A Rejto, Neil W Gibson, David J Po
    Nature Genetics.2011; 43(12): 1219.     CrossRef
  • High frequency of TTK mutations in microsatellite-unstable colorectal cancer and evaluation of their effect on spindle assembly checkpoint
    Iina Niittymäki, Alexandra Gylfe, Leena Laine, Marko Laakso, Heli J. Lehtonen, Johanna Kondelin, Jaana Tolvanen, Kari Nousiainen, Jeroen Pouwels, Heikki Järvinen, Kyösti Nuorva, Jukka-Pekka Mecklin, Markus Mäkinen, Ari Ristimäki, Torben F. Ørntoft, Sampsa
    Carcinogenesis.2011; 32(3): 305.     CrossRef
  • Physiological Relevance of Cell Cycle Kinases
    Marcos Malumbres
    Physiological Reviews.2011; 91(3): 973.     CrossRef
  • 11,645 View
  • 88 Download
  • 20 Crossref
Close layer
Case Reports
Mixed Testicular Germ Cell Tumor Presenting as Metastatic Pure Choriocarcinoma Involving Multiple Lung Metastases That Was Effectively Treated with High-dose Chemotherapy
Sang-Cheol Lee, Kyoung Ha Kim, Sung Han Kim, Nam Su Lee, Hee Sook Park, Jong-Ho Won
Cancer Res Treat. 2009;41(4):229-232.   Published online December 31, 2009
DOI: https://doi.org/10.4143/crt.2009.41.4.229
AbstractAbstract PDFPubReaderePub

Choriocarcinoma in the testis is very rare, and it represents less than 1% (0.3%) of all the testicular germ cell tumors. It is a particularly aggressive variant of non-seminoma tumor, which is characterized by a high serum β-HCG level and multiple lung metastases. The optimal management for this disease remains undefined. We report here on a case of choriocarcinoma with multiple lung metastases, and the patient has achieved continuous remission for 2 years after combination chemotherapy of BEP (bleomycin, etoposide and cisplatin) and sequential high-dose chemotherapy with autologous peripheral stem cell rescue.

Citations

Citations to this article as recorded by  
  • Testicular Mixed Germ Cell Tumor Presenting with Upper Gastrointestinal Bleeding: A Case Report
    Emilija Nikolovska Trpchevska, Beti Todorovska, Magdalena Bogdanovska Todorovska, Meri Trajkovska, Dafina Nikolova, Darko Dzambaz, Gjorgji Deriban, Fana Licoska-Josifovikj
    PRILOZI.2023; 44(2): 47.     CrossRef
  • Gastrointestinal Bleeding Secondary to Metastatic Duodenal Choriocarcinoma in a Patient with Concomitant Peptic Ulcer Disease
    Ahmed Elfiky, Asmaa Mokhtar, Mira Alsheikh, Hassan Almoussawi, Stephen Mulrooney, Haruhiko Sugimura
    Case Reports in Gastrointestinal Medicine.2021; 2021: 1.     CrossRef
  • Gastrointestinal Bleeding with Hemodynamic Repercussion due to a Gastric Metastatic Lesion of a Testicular Choriocarcinoma in a Previously Asymptomatic Young Adult
    Omar Al Salman, Fahad Malik, Shashank Trivedi, Marwah Alchalabi, Shobhana Chaudhari
    GE - Portuguese Journal of Gastroenterology.2020; 27(3): 212.     CrossRef
  • Choriocarcinomas May Be Presented with Abnormal Manifestations
    Alpaslan Tanoglu, Tolga Duzenli
    International Journal of Cancer Management.2017;[Epub]     CrossRef
  • Metastatic Testicular Choriocarcinoma: A Rare Cause of Upper GI Bleeding
    Kirsty Lowe, Jacqueline Paterson, Sharon Armstrong, Shaun Walsh, Max Groome, Craig Mowat
    ACG Case Reports Journal.2016; 3(1): 36.     CrossRef
  • Metastatic choriocarcinoma induced separate simultaneous intracerebral haemorrhages: a very rare occurrence and its novel association with Klinefelter syndrome
    Maximilian Olavi Joret, Robert M Starke, John Scotter, Peter Heppner
    BMJ Case Reports.2015; : bcr2015212777.     CrossRef
  • Contrast-Enhanced Ultrasonography of the Testes
    Ounali S. Jaffer, Paul S. Sidhu
    Ultrasound Clinics.2013; 8(4): 509.     CrossRef
  • Multiparametric ultrasonography of the testicles
    Tobias De Zordo, Daniel Stronegger, Leo Pallwein-Prettner, Chris J. Harvey, Germar Pinggera, Werner Jaschke, Friedrich Aigner, Ferdinand Frauscher
    Nature Reviews Urology.2013; 10(3): 135.     CrossRef
  • A Case of Gastrointestinal Bleeding due to Duodenal Metastasis from a Testicular Choriocarcinoma
    Magdalene Vardaros, Miral Subhani, Kaleem Rizvon, Vladimir Gotlieb, Paul Mustacchia, Lester Freedman, Vikas Garg, Jaspreet Singh, Ghulam Siddiqui
    Journal of Gastrointestinal Cancer.2013; 44(2): 234.     CrossRef
  • Unravelling mechanisms of cisplatin sensitivity and resistance in testicular cancer
    R. Koster, M.A.T.M. van Vugt, H. Timmer-Bosscha, J.A. Gietema, S. de Jong
    Expert Reviews in Molecular Medicine.2013;[Epub]     CrossRef
  • 14,956 View
  • 69 Download
  • 10 Crossref
Close layer
A Case of Desmoplastic Small Round Cell Tumor Diagnosed in a Young Female Patient
Ji-Won Kim, Jin Hyun Park, Hyeon Jin Cho, Ji-Hyun Kwon, Youngil Koh, Su-Jung Kim, Se Hyung Kim, Se-Hoon Lee, Seock-Ah Im, Yong-Tae Kim, Woo Ho Kim
Cancer Res Treat. 2009;41(4):233-236.   Published online December 31, 2009
DOI: https://doi.org/10.4143/crt.2009.41.4.233
AbstractAbstract PDFPubReaderePub

Desmoplastic small round cell tumor is a very rare malignancy. We report the case of a 26-year-old woman who suffered from dyspepsia and abdominal pain for 2 months. We performed an endoscopic biopsy of the duodenal mass and diagnosed her disease as desmoplastic small round cell tumor using immunohistochemical staining, fluorescence in situ hybridization, and reverse transcriptase polymerase chain reaction. Because the mass invaded the pancreas and superior mesenteric vein as well as duodenum and the disease was disseminated to liver and peritoneum, she received palliative chemotherapy using vincristine, doxorubicin, cyclophosphamide, ifosfamide, and etoposide. The maximal response to chemotherapy was stable disease. The patient expired 9 months after diagnosis.

Citations

Citations to this article as recorded by  
  • Intra-Abdominal Desmoplastic Small Round Cell Tumor: Current Treatment Options and Perspectives
    Guixia Wei, Xinyao Shu, Yuwen Zhou, Xia Liu, Xiaorong Chen, Meng Qiu
    Frontiers in Oncology.2021;[Epub]     CrossRef
  • A Case Report of Abdominal Desmoplastic Small Round Cell Tumor in a Young Tunisian Woman
    Karim Nacef, Mohamed Ali Chaouch, Rym Bouriga, Mohamed Ben Khalifa, Asma Chaouch, Mossab Ghannouchi, Moez Boudokhane
    Journal of Gastrointestinal Cancer.2019; 50(3): 568.     CrossRef
  • Primary desmoplastic small-round-cell tumor of the ovary
    Ahmed Atef, Khaled Gaballa, Mohammad Zuhdy, Khalid Atallah, Wagdi Elkashef, Shadi Awny, Basma Gadelhak, Basel Refky
    Journal of the Egyptian National Cancer Institute.2019;[Epub]     CrossRef
  • Tumor intraabdominal desmoplásico de células pequeñas y redondas
    Andrés Alejandro Briseño-Hernández, Deissy Roxana Quezada-López, Lilia Edith Corona-Cobián, Agar Castañeda-Chávez, Alfonso Tonatiuh Duarte-Ojeda, Michel Dassaejv Macías-Amezcua
    Cirugía y Cirujanos.2015; 83(3): 243.     CrossRef
  • Intra-abdominal desmoplastic small round cell tumour
    Andrés Alejandro Briseño-Hernández, Deissy Roxana Quezada-López, Lilia Edith Corona-Cobián, Agar Castañeda-Chávez, Alfonso Tonatiuh Duarte-Ojeda, Michel Dassaejv Macías-Amezcua
    Cirugía y Cirujanos (English Edition).2015; 83(3): 243.     CrossRef
  • Primary desmoplastic small round cell tumor of the duodenum
    Qi Liu, Nan Liu, DeXing Chen
    European Journal of Medical Research.2014;[Epub]     CrossRef
  • Tumor desmoplásico de células pequeñas y redondas. Diagnóstico y tratamiento
    Izaskun Markinez Gordobil, Inmaculada Ruiz, Raúl Jiménez, Eloisa Villarreal, Aintzane Lizarazu, Nerea Borda, Xabier Arteaga, Miguel Ángel Medrano, Esther Guisasola, Adolfo Beguiristain, José María E. Navascués
    Gaceta Médica de Bilbao.2012; 109(3): 101.     CrossRef
  • Desmoplastic small round cell tumor of the abdomen: A case report and literature review of therapeutic options
    Hafida Benhammane, Leila Chbani, Abdelmalek Ousadden, Ouadii Mouquit, Siham Tizniti, Afaf Riffi Amarti, Nouafal Mellas, Omar El Mesbahi
    Health.2012; 04(04): 207.     CrossRef
  • Analysis of Prognostic Factors of Pediatric-Type Sarcomas in Adult Patients
    Hee Kyung Ahn, Ji Eun Uhm, Jeeyun Lee, Do Hoon Lim, Sung Wook Seo, Ki-Sun Sung, Su Jin Lee, Duk Joo Lee, Kyung Kee Baek, Won-Seog Kim, Joon Oh Park
    Oncology.2011; 80(1-2): 21.     CrossRef
  • 11,762 View
  • 62 Download
  • 9 Crossref
Close layer
Pseudoaneurysm Due to Squamous Cell Carcinoma of the Lung: Two Cases of Spontaneous Resolution after Chemotherapy
So-Young Kim, Hak-Ryul Kim, Jung-Sub Song, Ki-Eun Hwang, Jeong-Hyun Shin, Seoung-Nam Shin, Dong Kim, Seong-Hoon Park, Sei-Hoon Yang, Eun-Taik Jeong
Cancer Res Treat. 2009;41(4):237-240.   Published online December 31, 2009
DOI: https://doi.org/10.4143/crt.2009.41.4.237
AbstractAbstract PDFPubReaderePub

Pseudoaneurysm due to cancer is uncommon generally and is extremely rare in lung cancer. We report two cases of false aneurysms due to lung cancer that spontaneously regressed upon chemotherapy without intervention. Both patients had squamous cell carcinoma of the lung and the diagnosis of a pseudoaneurysm was made using computed tomography. There was no evidence of severe bronchial hemorrhage and the psuedoaneurysms were small and well-encased. Chemotherapy was performed and the pseudoaneurysms resolved.

Citations

Citations to this article as recorded by  
  • Left Pulmonary Artery Aneurysm Secondary to Metastatic Lung Sarcoma: A Case Report
    Muhammad Abdullah Javed, Kaleem S Ahmed, Mohammad Bin Pervez, Saira Fatima, Saulat Hasnain Fatimi
    Cureus.2023;[Epub]     CrossRef
  • Fatal rupture of pulmonary artery pseudoaneurysm after thoracic radiation therapy against lung squamous cell carcinoma: A case report and literature review
    Yosuke Fukuda, Tetsuya Homma, Tomoki Uno, Yasunori Murata, Shintaro Suzuki, Eisuke Shiozawa, Masafumi Takimoto, Hironori Sagara
    Clinical Case Reports.2021; 9(2): 737.     CrossRef
  • Embolisation of large pulmonary artery pseudoaneurysm with conservative treatment of delayed coil extrusion
    S Elangovan, CW Too
    Singapore Medical Journal.2020; 61(3): 162.     CrossRef
  • An unusual presentation of pulmonary artery sarcoma: Several pseudoaneurysms with massive hemoptysis
    Oguzhan Yildiz, Emre Unal, Turkmen Turan Ciftci, Devrim Akinci, Orhan Macit Ariyurek
    The American Journal of Emergency Medicine.2020; 38(9): 1966.e1.     CrossRef
  • Pseudoaneurysm of the aortic arch
    Yuan-Qiang Lu, Feng Yao, An-Dong Shang, Jian Pan
    Medicine.2016; 95(31): e4457.     CrossRef
  • Pseudoaneurysm of pulmonary artery: rare complication of systemic chemotherapy
    Shivani Garg, Gentry King, Gabor Varadi
    Clinical Case Reports.2015; 3(10): 845.     CrossRef
  • Aneurysms and Pseudoaneurysms of the Pulmonary Vasculature
    Carlos S. Restrepo, Aimee P. Carswell
    Seminars in Ultrasound, CT and MRI.2012; 33(6): 552.     CrossRef
  • A Case of Pseudoaneurysm Developed during Intensive Treatment of Status Asthmaticus - A Case Report -
    Dong Kim, Jeong-Hyun Shin, Dong-Hyo No, Hyeong-Cheol Cheong, Kyung-Hwa Cho, Ki-Eun Hwang, Hwi-Jung Kim, Eun-Taik Jeong, Hak-Ryul Kim
    The Korean Journal of Critical Care Medicine.2010; 25(4): 241.     CrossRef
  • 8,782 View
  • 69 Download
  • 8 Crossref
Close layer
A Case of Spine Origin Chondroblastoma Metastasis to Lung
Se Hoon Sohn, Sung Aee Koh, Dong Geun Kim, Sung Woo Park, Kyung Hee Lee, Min Kyoung Kim, Jun Hyuk Choi, Myung Soo Hyun
Cancer Res Treat. 2009;41(4):241-244.   Published online December 31, 2009
DOI: https://doi.org/10.4143/crt.2009.41.4.241
AbstractAbstract PDFPubReaderePub

Chondroblastoma is a rare benign cartilaginous neoplasm that accounts for approximately 1% of all bone tumors and characteristically arises in the epiphysis of a long bone, particularly the humerus, tibia, and femur. Chondroblastoma can affect people of all ages. It is, however, most common in children and young adults between the ages of 10 and 20 years. Although most chondroblastomas are cured by limited surgical procedures, occasional lesions behave more aggressively and may even metastasis. In this case a young man with pulmonary metastatic chondroblastoma on spine is presented. Unlike previously published examples of metastatic chondroblastoma, these metastasis developed before any operative manipulation of the primary tumor. And primary tumor site was also unusual. The histologic characteristics of the primary, metastatic tumors were those of a conventional chondroblastoma.

Citations

Citations to this article as recorded by  
  • A rare case of chondroblastoma of the jugular foramen: Imaging and pathological features
    Kai-Jie Wang, Tian-Cheng Lin, Wei-Yuan Huang
    Radiology Case Reports.2025; 20(5): 2527.     CrossRef
  • Malignant chondroblastoma of the rib with scalp metastases in an adult patient: case report with molecular characterization
    Eva Manuela Pena-Burgos, Carolina Agra-Pujol, Francisco Alijo-Serrano, Luis Lombardía Ferreira, Lydia Mediavilla Santos, Miguel Cuervo-Dehesa, Ángel Santos-Briz, Pilar Escalonilla García-Patos, Álfonso Tejerizo García, Mar Tapia-Viñe, Julia Suárez-Gonzále
    Virchows Archiv.2025;[Epub]     CrossRef
  • Chondroblastoma of Thoracic Vertebrae: a Case Report and Review of the Literature
    Alireza Tabibkhooei, Parisa Javadnia
    Indian Journal of Surgical Oncology.2024; 15(S1): 22.     CrossRef
  • Bone metastases from chondroblastoma: a rare pattern of metastatic disease in an adult
    Jennifer Murphy, Anish Patel, Simon Hughes, Petr Rehousek, John Drake, Vaiyapuri Sumathi, Rajesh Botchu, A. Mark Davies
    Skeletal Radiology.2024; 53(6): 1219.     CrossRef
  • Comprehensive Insights into Chondroblastoma Metastasis: Metastatic Patterns and Therapeutic Approaches
    Ramy Samargandi, Abrar Bafail, Louis-Romée Le Nail, Julien Berhouet
    Cancers.2024; 16(12): 2283.     CrossRef
  • Clinicopathological and Prognostic Characteristics in Spinal Chondroblastomas: A Pooled Analysis of Individual Patient Data From a Single Institute and 27 Studies
    Bo-Wen Zheng, Wei Huang, Fu-Sheng Liu, Tao-Lan Zhang, Xiao-Bin Wang, Jing Li, Guo-Hua Lv, Yi-Guo Yan, Ming-Xiang Zou
    Global Spine Journal.2023; 13(3): 713.     CrossRef
  • Chondroblastoma: clinicopathological analyses of 307 cases from a single institution in China and the diagnostic value of the H3F3 K36M mutant antibody
    Qianqian Zhao, Juan Tang, Yanli Luo, Jin Huang, Dingjun Hu, Jinyu Zhu, Ting Jiang, Huizhen Zhang, Zhiyan Liu
    Journal of Clinical Pathology.2023; 76(6): 367.     CrossRef
  • Clinicopathological characteristics and prognostic factors in axial chondroblastomas: a retrospective analysis of 61 cases and comparison with extra-axial chondroblastomas
    Bo-Wen Zheng, Bo-Yv Zheng, Hua-Qing Niu, Ming-Xiang Zou, Hai-Lin Wu, Ming Wang, Xue-Lin Li
    World Journal of Surgical Oncology.2023;[Epub]     CrossRef
  • Pulmonary Metastases of Chondroblastoma in a Pediatric Patient: A Case Report and Review of Literature
    Courtney Wing, Pankaj Watal, Monica Epelman, Juan Infante, Tushar Chandra
    Cureus.2022;[Epub]     CrossRef
  • Missed radiographic and clinical findings in a case of non-idiopathic scoliosis resulting from chondroblastoma
    Navraj S. Sagoo, Edward P. Southern, Andrew G. King, Matthew W. Stark, Lori A. McBride
    Spine Deformity.2021; 9(1): 297.     CrossRef
  • Sacral chondroblastoma — a rare location, a rare pathology: A case report and review of literature
    Bo-Wen Zheng, Hua-Qing Niu, Xiao-Bin Wang, Jing Li
    World Journal of Clinical Cases.2021; 9(20): 5709.     CrossRef
  • Chondroblastoma of the knee in a teenager
    Maitham Alkadumi, Neil Duggal, Sukhman Kaur, Joseph Dobtsis
    Radiology Case Reports.2021; 16(12): 3729.     CrossRef
  • Pediatric Chondroblastoma and the Need for Lung Staging at Presentation
    Alexandre Arkader, Amy Williams, Odion Binitie, Mihir M. Thacker, German L. Farfalli
    Journal of Pediatric Orthopaedics.2020; 40(9): e894.     CrossRef
  • Chondroblastoma Expresses RANKL by RNA In Situ Hybridization and May Respond to Denosumab Therapy
    David I. Suster, Pawel Kurzawa, Azfar Neyaz, Jason A. Jarzembowski, Santiago Lozano-Calderon, Kevin Raskin, Joseph Schwab, Edwin Choy, Ivan Chebib, Vikram Deshpande
    American Journal of Surgical Pathology.2020; 44(12): 1581.     CrossRef
  • Histone H3K36M mutation and trimethylation patterns in chondroblastoma
    Chuanyong Lu, Daniel Ramirez, Sinchun Hwang, Achim Jungbluth, Denise Frosina, Peter Ntiamoah, John Healey, Guo Zhu, Wen Chen, Michael Klein, Meera Hameed
    Histopathology.2019; 74(2): 291.     CrossRef
  • Chondroblastoma of bone in extremities. - A single centre study of 177 cases
    M.K. Laitinen, J.D. Stevenson, S. Evans, A. Abudu, V. Sumathi, L.M. Jeys, M.C. Parry
    Journal of Bone Oncology.2019; : 100248.     CrossRef
  • Clinical features, treatments and long-term follow-up outcomes of spinal chondroblastoma: report of 13 clinical cases in a single center
    Qi Jia, Chao Liu, Jian Yang, Yong Ji, Haifeng Wei, Tielong Liu, Xinghai Yang, Cheng Yang, Jianru Xiao
    Journal of Neuro-Oncology.2018; 140(1): 99.     CrossRef
  • Chondroblastoma: An evaluation of the recurrences and functional outcomes following treatment
    Devrim Özer, Yavuz Arıkan, Volkan Gür, Cantay Gök, Yunus Emre Akman
    Acta Orthopaedica et Traumatologica Turcica.2018; 52(6): 415.     CrossRef
  • Condroblastoma óseo
    F. Sailhan, M. Bachy, B. Tomeno, V. Dumaine, A. Babinet, P. Anract
    EMC - Aparato Locomotor.2014; 47(1): 1.     CrossRef
  • Chondroblastoma of the Navicular Bone
    XiaoNa Li, ZhiGang Peng, JingPin Zhao, ZeKun Zhang
    Iranian Journal of Radiology.2014;[Epub]     CrossRef
  • Douleur de l’épaule révélant un chondroblastome huméral
    A. Zrig, M. Zrig, W. Mnari, H. El Mhabrech, R. Salem, A. Abid, M. Golli
    Archives de Pédiatrie.2014; 21(12): 1386.     CrossRef
  • Chondroblastoma of the Knee Treated with Resection and Osteochondral Allograft Reconstruction
    Judd Fitzgerald, Cory Broehm, David Chafey, Gehron Treme
    Case Reports in Orthopedics.2014; 2014: 1.     CrossRef
  • Chondroblastoma of the Lumbar Vertebra Associated with Cauda Equina Compression
    Yeap Ewe-Juan, Siow Yew-Siong, Deepak Ajit-Singh
    Journal of Orthopaedics, Trauma and Rehabilitation.2013; 17(2): 99.     CrossRef
  • A Massive Chondroblastoma in the Proximal Humerus Simulating Malignant Bone Tumors
    Ichiro Tonogai, Mitsuhiko Takahashi, Hiroaki Manabe, Toshihiko Nishisho, Seiji Iwamoto, Shoichiro Takao, Seiko Kagawa, Eiji Kudo, Natsuo Yasui
    Case Reports in Orthopedics.2013; 2013: 1.     CrossRef
  • 11,530 View
  • 80 Download
  • 24 Crossref
Close layer

Cancer Res Treat : Cancer Research and Treatment
Close layer
TOP